ARCHIVES

NCAB Says Restrictions on Animal Research Threatens Progress

This article is from The Cancer Letter archive.

Vol. 14 No. 21 | May 20, 1988

Download PDF Visit The Full Archive

Related Articles

PDQ Evaluation to Cost NCI More Than Reported

June 29, 1990

FDA Rile Changes Reporting Requirements for Adverse Events

November 18, 1994

NCI Payline In 1985 Likely To Be 170; $5.9 Million To Be Diverted to AIDS

December 7, 1984

Piperacillin/Tazobactam Valuable Empiric Therapy For Febrile Neutropenia

October 31, 2003

Emphasis On Early Disease In Clinical Trials, Early Lung Cancer Detection Seen As “Landmark”

September 19, 1975

USPSTF and ACS Recommend Less Frequent Cervical Cancer Screenings and Pap Smears

March 30, 2012